Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Idiopathic Inflammatory Myopathies; Systemic Sclerosis Interventions: Biological: CD19-CAR-DNT cells Sponsors: RenJi Hospital; Guangdong Ruishun Biotech Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Autoimmune Disease | Biotechnology | Hospitals | Lupus | Research | Scleroderma | Study | Vasculitis